BioCryst Pharmaceuticals
BCRX | NASDAQ
$7.45
-$0.16 (-2.10%)
At close: Nov 16, 2026, 4:00 PM ET
$7.64
+$0.19 (+2.58%)
After-hours:
Nov 16, 2026, 7:30 PM ET
BioCryst Pharmaceuticals Institutional Ownership
Institutional ownership explainedInstitutional Ownership
Net InflowTotal Institutions
335
Total Ownership
108.95%
Capital Flow
+$265.26M
Shares Change
+14.65M
Ownership Distribution
Institutions (99.99%)
Others (0.01%)
Institutional Sentiment
Overall: bullishEquity Sentiment & Activity
bullishNew Positions
57
Increased Positions
189
Reduced Positions
89
Closed Positions
40
New (57)
Increased (189)
Reduced (89)
Closed (40)
Options Sentiment & Activity
bullishPut/Call Ratio
0.291
Call Flow
1,838,013
Put Flow
535,500
Calls (77%)
Puts (23%)
Super Investors
| Super Investor / Fund | Ownership | Portfolio Weight | Shares | Market Value | |
|---|---|---|---|---|---|
| Fisher Asset Management LLC | 1.02% -4.73% | < 0.01% | 2.6M | 22.19M | |
| Renaissance Technologies LLC | 0.99% +225.65% | 0.03% | 2.53M | 21.56M | |
| Moore Capital Management LP | 0.33% 0.00% | 0.12% | 848.34K | 6.85M |
Top Shareholders
| Institution | Ownership | Portfolio Weight | Shares | Market Value | |
|---|---|---|---|---|---|
| Blackrock, Inc. | 9.39% +0.42% | < 0.01% -5.76% | 23.89M +5.48% | 238.93M +10.80% | |
| State Street Corp | 6.27% +24.43% | < 0.01% +11.84% | 15.19M +24.43% | 151.91M +30.71% | |
| Ra Capital Management, L.p. | 6.22% -4.80% | 1.38% -13.85% | 15.83M 0.00% | 158.27M +5.04% |
Pro Membership
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
Unlimited access
Unlimited access to all data and tools, giving you the edge over everyone else in the market.
Proprietary Stock Rating Score
Evaluate stocks with our proprietary rating score based on fundamentals, economic moat, and sentiment.
Top Wall Street Analyst Ratings
Follow ratings from the best analysts on Wall Street to stay ahead of market moves.
Up to 30 years financial history
We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Add to Watchlist
Select watchlists to add or remove BCRX